AC
GNMK

Athos Capital’s GenMark Diagnostics, Inc GNMK Stock Holding History

Athos Capital’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200,000
Closed -$4.78M – 235
2021
Q1 		$4.78M Buy
+200,000
New +$3.72M 0.8% 27

Athos Capital's GNMK Position: Q2 2021 in Review

Athos Capital sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 200,000 shares — an estimated $4.78M sold.

Athos Capital first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $4.78M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Athos Capital reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Athos Capital sold 200,000 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $4.78M.
  • Athos Capital first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Athos Capital's GenMark Diagnostics, Inc position peaked at $4.78M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Athos Capital's 13F filing for Q2 2021, filed 12 Aug 2021.